Detalhe da pesquisa
1.
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.
Front Pharmacol
; 13: 856846, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263136
2.
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Cannabis Cannabinoid Res
; 7(5): 658-669, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34619044
3.
Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical Trial.
JAMA Netw Open
; 4(8): e2120603, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387679